You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

 

Online download statistics by month:

Online download statistics by month: February 2023 to July 2025

AbstractFullPdf
Feb 2023493500206
Mar 2023377380133
Apr 202314914953
May 202311611628
Jun 2023929220
Jul 202311111137
Aug 202312012024
Sep 2023686816
Oct 2023818238
Nov 202310010037
Dec 2023727343
Jan 202412612665
Feb 2024858548
Mar 2024868847
Apr 2024969662
May 2024747460
Jun 2024676735
Jul 2024737646
Aug 2024656731
Sep 2024838338
Oct 2024757541
Nov 2024939445
Dec 202410210634
Jan 2025939345
Feb 202514814827
Mar 2025747456
Apr 202512112155
May 2025727252
Jun 2025565647
Jul 2025110
Total336933931469